@article{paternot:hal-03898858,
TITLE = {Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition},
AUTHOR = {Paternot, Sabine and Rasp{\'e},
Eric and Meiller, C and Tarabichi, Maxime and Assi{\'e},
Jean-Baptiste and Libert, Frederick and Remmelink, Myriam and Bisteau, Xavier and Pauwels, Patrick and Blum, Yuna and Le-Stang, Nolwenn and Tabone-Eglinger, Severine and Galateau-Sall{\'e},
Fran{\c c}oise and Blanquart, Christophe and van Meerbeeck, Jan P and Berghmans, Thierry and Jean, Didier and Roger, Pierre P.},
URL = {https://hal.science/hal-03898858},
JOURNAL = {Molecular Oncology},
PUBLISHER = {Elsevier},
YEAR = {2023},
DOI = {10.1002/1878-0261.13351},
KEYWORDS = {CDK4 Thr172-phosphorylation ; Mesothelioma ; biomarker ; cell cycle ; palbociclib ; senescence-associated secretory phenotype},
PDF = {https://hal.science/hal-03898858/file/2022%20Paternot%20et%20al%2C%20Molecular%20Oncology.pdf},
HAL_ID = {hal-03898858},
HAL_VERSION = {v1},
}